Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD 145.96
-1.85 (-1.25%)
At close: Oct 17, 2025
Masimo Employees
Masimo had 3,600 employees as of December 28, 2024. The number of employees decreased by 200 or -5.26% compared to the previous year.
Employees
3,600
Change (1Y)
-200
Growth (1Y)
-5.26%
Revenue / Employee
436.26K GBP
Profits / Employee
-93.01K GBP
Market Cap
5.95B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 3,600 | -200 | -5.26% |
| Dec 30, 2023 | 3,800 | -200 | -5.00% |
| Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
| Jan 1, 2022 | 2,200 | 200 | 10.00% |
| Jan 2, 2021 | 2,000 | 400 | 25.00% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,500 |
Masimo News
- 1 day ago - Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock - Benzinga
- 9 days ago - Masimo to Host Investor Day on December 3, 2025 - Business Wire
- 11 days ago - In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones - Business Wire
- 15 days ago - Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Nasdaq
- 15 days ago - Is the Options Market Predicting a Spike in Masimo Stock? - Nasdaq
- 19 days ago - Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today - Benzinga
- 22 days ago - Joe Kiani: A Year of Reinvention and Impact Beyond Masimo - CEOWORLD magazine
- 23 days ago - Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI - Nasdaq